How immunotherapy is improving outlook for melanoma patients
Melanoma is the deadliest form of skin cancer in the world. While traditional therapies include chemotherapy, radiation, and surgery, immunotherapy
Read more
immunotherapy
From the labs to bedside: First-in-human trial shows promise in treating neuroblastoma
Neuroblastoma is the most common extracranial solid cancer in children, and patients with high-risk disease are challenging to treat. In April,
Read more
Special delivery of IL-7 signaling makes all the difference for CAR T cells fighting solid tumors
Since he was in college, Thomas Shum wanted to pursue a career in cancer research. As he advanced in his
Read more
Immunotherapy treatment gives lung cancer patient second chance
A few years ago, Katherine Dill was leading a full life with her two children in Texas when she noticed
Read more
How immunotherapy is transforming cancer treatment and patient care
From surgical intervention to targeted therapies, a wide range of treatment options are now available for many patients with cancer.
Read more
“Off-the-shelf” cells are safe and effective to treat viral infections
A bone marrow transplant can be a life-saving treatment for patients with certain cancers and other serious illnesses that have
Read more
Mouse blood vessels and immune system can team up against cancer metastasis
Picture a shapeless, small mass of tumor cells inside an otherwise healthy organ. The tumor is growing, thanks, among other
Read more
How understanding tumor diversity can potentially improve the outcomes of patients with lung cancer
[See video below] “People may think of lung cancer as one disease, but lung cancer is a collection of diverse
Read more
Targeting two cell surface molecules can mitigate escape of solid glioblastoma tumors
One strategy to fight cancer cells involves ‘training’ the individual’s own immune system to fight the tumor, what is called
Read more
Targeting B-cell malignancies with κ-specific T cells can lead to complete clinical responses
Treating cancer with the patient’s own immune cells has been successful. In particular, treating B cell malignancies with the patients’
Read more